DJIA 17,202.71 -77.03 -0.45%
NASDAQ 4,519.50 -60.29 -1.32%
S&P 500 1,995.24 -15.16 -0.75%
market minute promo

Abbott Laboratories (NYSE: ABT)

43.30 -0.30 (-0.68%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ABT $43.30 -0.68%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.59
Previous Close $43.59
Daily Range $43.22 - $43.67
52-Week Range $32.75 - $44.20
Market Cap $65.1B
P/E Ratio 31.59
Dividend (Yield) $0.88 (2.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,939,597
Average Daily Volume 3,851,715
Current FY EPS $2.26





Abbott Laboratories (ABT) Description

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Website:

News & Commentary Rss Feed

Dividend Aristocrats: Time to Buy AbbVie Inc Stock?

AbbVie is an innovative pharma company with an attractive yield and a strong outlook for top-line growth going forward. Here's why investors should dig into this top dividend stock.

Abbott Labs (ABT) to Initiate New Trial on Absorb - Analyst Blog

3 Health Services Stocks Pushing The Industry Higher

JNK, RXL: Big ETF Outflows

Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away

10 Stocks Giving Investors More Money

Study Shows Medtronic’s CoreValve TAVR Device Has Consistent And Cost Effective Performance

Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog

Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog

Update: Abbott To Invest $60 Million In An Intraocular Lens Plant In Malaysia

Attunity, Ltd. (ATTU) in Focus: Stock Adds 5.2% in Session - Tale of the Tape

See More ABT News...

ABT's Top Competitors

ABT $43.30 (-0.68%)
Current stock: ABT
JNJ $107.88 (-0.10%)
Current stock: JNJ
PFE $30.05 (-1.15%)
Current stock: PFE
RHHBY $37.66 (0.05%)
Current stock: RHHBY